首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human CD152 Recombinant Antibody(Tremelimumab)

Anti-Human CD152 Recombinant Antibody(Tremelimumab)

产品编号

YR1160

别名

科研级 Tremelimumab ( 曲美木单抗 ), Anti-CD152 Recombinant Antibody, Research Grade Tremelimumab

规格
  • 1mg
  • 5mg
产品介绍
Catalog NumberYR1160
Alias科研级 Tremelimumab ( 曲美木单抗 ), Anti-CD152 Recombinant Antibody, Research Grade Tremelimumab
Size1mg, 5mg
Molecular NameTremelimumab
CAS Number745013-59-6
TargetCD152[Homo sapiens]
Antibody IsotypeIgG2 Kappa
ClonityMonoclonal
Concentration1mg/ml
Purity>95% as determined by SDS-PAGE
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
FormulationPBS, pH7.5
Shipping ConditionShipped on ice packs.
BackgroundTremelimumab (formerly ticilimumab, CP-675, 206) is a fully human monoclonal antibody against CTLA-4. It is an immune checkpoint blocker. Previously in development by Pfizer, it is now in investigation by MedImmune, a wholly owned subsidiary of AstraZeneca. It has been undergoing human trials for the treatment of various cancers but has not attained approval for any.
ApplicationIF, IP, Neut, FuncS, ELISA
RemarksThis product is for research use only.

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价